Plexus (PLXS) Expected to Announce Quarterly Earnings on Wednesday

Plexus (NASDAQ:PLXS) will likely be issuing its Q2 2026 results after the market closes on Wednesday, April 22nd. Analysts expect the company to announce earnings of $1.88 per share and revenue of $1.1309 billion for the quarter. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, April 23, 2026 at 8:30 AM ET.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. The business had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.Plexus’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.73 earnings per share. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Price Performance

NASDAQ:PLXS opened at $227.95 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. The stock’s 50-day simple moving average is $202.21 and its 200 day simple moving average is $170.82. The company has a market cap of $6.11 billion, a P/E ratio of 35.45 and a beta of 0.75. Plexus has a 52-week low of $115.35 and a 52-week high of $232.17.

Insider Buying and Selling at Plexus

In related news, COO Oliver K. Mihm sold 9,541 shares of Plexus stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the completion of the transaction, the chief operating officer owned 12,809 shares in the company, valued at approximately $2,579,732.60. This trade represents a 42.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 8,120 shares of Plexus stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $205.65, for a total value of $1,669,878.00. Following the transaction, the chief executive officer owned 78,598 shares of the company’s stock, valued at $16,163,678.70. The trade was a 9.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 49,495 shares of company stock valued at $10,009,836 in the last three months. Corporate insiders own 1.78% of the company’s stock.

Hedge Funds Weigh In On Plexus

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Corient Private Wealth LLC grew its holdings in Plexus by 6.1% during the fourth quarter. Corient Private Wealth LLC now owns 1,929 shares of the technology company’s stock worth $284,000 after purchasing an additional 111 shares during the period. Caitlin John LLC bought a new position in Plexus during the fourth quarter worth about $408,000. Fuller & Thaler Asset Management Inc. grew its holdings in Plexus by 5.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 446,705 shares of the technology company’s stock worth $65,666,000 after purchasing an additional 24,441 shares during the period. XTX Topco Ltd bought a new position in Plexus during the fourth quarter worth about $758,000. Finally, Palisade Capital Management LP bought a new stake in shares of Plexus during the fourth quarter worth approximately $2,003,000. Institutional investors own 94.45% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on PLXS shares. Weiss Ratings raised Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, March 6th. Williams Trading set a $195.00 target price on Plexus in a research report on Wednesday, January 28th. Benchmark reaffirmed a “buy” rating and issued a $220.00 target price on shares of Plexus in a research report on Monday, March 16th. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Finally, Needham & Company LLC lifted their target price on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Plexus has a consensus rating of “Moderate Buy” and an average target price of $194.20.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.